Lumida
/ADN
⌘K
ADN

ADN

ADN
$0.92USD-66.11%-1.79 today

MARKET CAP

1.4M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$9
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$7.1M$7.8M$1.5M$3.3M
YoY %+10.9%-80.4%+113.3%
P / Sales
EV / Sales
Gross Profit, Adj.$1.7M$-744,000$-5.4M$1.8M
YoY %-144.7%-629.6%+132.9%
Margin %23.5%-9.5%-353.4%54.6%
EV / Gross Profit
EBITDA, Adj.$-43.2M$-46.1M$-38.4M$-16.8M
YoY %-6.7%+16.6%+56.3%
Margin %-611.1%-588.0%-2501.2%-512.1%
EV / EBITDA
EBIT$-44.9M$-89.3M$-50.7M$-18.4M
YoY %-98.6%+43.2%+63.8%
Margin %-635.7%-1138.9%-3301.6%-560.7%
EV / EBIT
Net Income$-20.5M$-74.3M$-71.4M$-41.0M
YoY %-262.2%+4.0%+42.6%
Net Margin-290.3%-948.5%-4648.2%-1251.3%
EPS (GAAP)-$13.50-$43.28-$37.24-$15.65
YoY %-220.6%+14.0%+58.0%